Recap: Xeris Biopharma Holdings Q4 Earnings

Xeris Biopharma Holdings XERS reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Xeris Biopharma Holdings missed estimated earnings by 75.0%, reporting an EPS of $-0.42 versus an estimate of $-0.24.

Revenue was up $14.34 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 9.47% increase in the share price the next day.

Here's a look at Xeris Biopharma Holdings's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.37	-0.30	-0.34	-0.38
EPS Actual	-0.39	-0.41	-0.30	-0.41
Revenue Estimate	11.03M	9.54M	7.47M	8.21M
Revenue Actual	11.04M	8.84M	8.05M	7.09M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar